Clinical Trial Update: Ruxolitinib in Combination With Autotransplant [NA]

View source ↗

Summary

A clinical trial evaluating ruxolitinib in combination with autotransplant for myelofibrosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Marina Kremyanskaya | Conditions: Myelofibrosis, MF | NA | Status: WITHDRAWN